DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 3, 2014--
Alkermes plc (NASDAQ: ALKS)
announced today that it will webcast a live fireside chat, featuring
Richard Pops, at the 16th Annual BIO CEO & Investor
Conference on Monday, Feb. 10, 2014, at 8:00 a.m. EST (1:00 p.m. GMT)
from the Waldorf Astoria Hotel in New York City. The fireside chat will
be moderated by David Gluckman, M.D., Managing Director, Global Co-Head
of Healthcare, Lazard Ltd. In addition, Alkermes’ corporate presentation
will be webcast live at the Leerink Swann Global Healthcare Conference
2014 on Wednesday, Feb. 12, 2014, at 8:50 a.m. EST (1:50 p.m. GMT), also
from the Waldorf Astoria Hotel in New York City. These presentations may
be accessed under the Investors tab on www.alkermes.com
and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company
that applies its scientific expertise and proprietary technologies to
develop innovative medicines that improve patient outcomes. The company
has a diversified portfolio of more than 20 commercial drug products and
a substantial clinical pipeline of product candidates that address
central nervous system (CNS) disorders such as addiction, schizophrenia
and depression. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and manufacturing facilities in
Gainesville, Georgia and Wilmington, Ohio. For more information, please
visit Alkermes’ website at www.alkermes.com.
Source: Alkermes plc
Alkermes plc
Eva Stroynowski, +1-781-609-6823
Corporate
Communications
